Francesca Hilder
Papers
1
Total Citations
1
H-Index
1
About
Francesca Hilder is a clinical researcher whose work centers on the comparative effectiveness of treatment modalities for oropharyngeal carcinoma, with a particular focus on p16-positive (HPV-related) disease. Her major contribution lies in rigorously evaluating oncological and functional outcomes between transoral robotic surgery (TORS) and primary radiotherapy for early-stage (T1-2 N0-1) patients. Her most cited paper, published in 2025, provides critical evidence comparing these two approaches, analyzing survival, swallowing function, and quality of life in a cohort of p16+ oropharyngeal squamous cell carcinoma patients. This work directly informs the ongoing debate between surgical and non-surgical management of HPV-positive throat cancer, a rapidly growing patient population. While her citation count is still emerging, the clinical relevance of her research—addressing the balance between cancer control and functional preservation—positions her as a rising voice in head and neck oncology. Her findings are particularly valuable for multidisciplinary tumor boards and for patients weighing treatment options that impact long-term speech and swallowing.
Research Focus
Key Achievements
Top Papers
- 1